Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127704611 | 12770461 | 1 | I | 20160912 | 20160922 | 20160922 | EXP | US-JNJFOC-20160913253 | JOHNSON AND JOHNSON | 0.00 | E | F | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127704611 | 12770461 | 1 | SS | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | U | U | 0 | TABLET | ||||||||
127704611 | 12770461 | 2 | PS | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | U | U | 999999 | TABLET | ||||||||
127704611 | 12770461 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | D | 0 | 5 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127704611 | 12770461 | 1 | Urticaria |
127704611 | 12770461 | 2 | Drug hypersensitivity |
127704611 | 12770461 | 3 | Cardiac disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127704611 | 12770461 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127704611 | 12770461 | Loss of consciousness | |
127704611 | 12770461 | Off label use | |
127704611 | 12770461 | Overdose | |
127704611 | 12770461 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127704611 | 12770461 | 3 | 2000 | 0 |